银屑病、代谢综合征与心血管危险因素:一项基于人群的研究
在西班牙莱里达基于医院与初级保健联合数据库的观察性横断面人群研究中,共纳入398701人,其中银屑病6868例(1.7%),中重度银屑病499例(7.3%)。银屑病患者传统心血管危险因素、代谢综合征及主要心血管事件患病率均高于非银屑病人群,但心血管危险因素在银屑病严重程度组间相似。
要点
- 银屑病患者代谢综合征患病率28.3%,高于非银屑病人群的15.1%(OR 2.21)。
- 银屑病患者2型糖尿病、血脂异常、高血压患病率均高于非银屑病人群。
- 心血管危险因素在银屑病严重程度组间相似,未见差异。
核心结论
- 银屑病患者心血管危险因素、代谢综合征及主要心血管事件患病率与非银屑病人群存在统计学显著差异,但未见于银屑病严重程度组间。
- 作者认为该工作强化了对这类患者采取多学科方法并密切监测心血管危险因素以预防心血管事件的必要性。
研究设计与样本
- 观察性横断面人群研究,数据来自西班牙莱里达的医院与初级保健联合数据库。
- 数据库共398701人,登记为银屑病者6868例(1.7%),其中499例(7.3%)分类为中重度银屑病。
主要发现
- 银屑病患者2型糖尿病患病率13.9% vs 非银屑病人群7.4%(OR 2.01)。
- 银屑病患者血脂异常患病率28.8% vs 非银屑病人群17.4%(OR 1.92)。
- 银屑病患者高血压患病率31.2% vs 非银屑病人群19.0%(OR 1.93)。
- 银屑病患者肥胖患病率33.7% vs 非银屑病人群28.1%(OR 1.30)。
- 银屑病患者空腹血糖异常患病率21.4% vs 非银屑病人群15.1%(OR 1.54)。
关键数值与推荐
- 低高密度脂蛋白胆固醇患病率38.1% vs 32.3%(OR 1.29)。
- 高甘油三酯血症患病率45.7% vs 35.2%(OR 1.55)。
- 腰围增高患病率75.7% vs 72.3%(OR 1.19)。
- 代谢综合征患病率28.3% vs 15.1%(OR 2.21)。
- 缺血性心脏病患病率3.3% vs 1.8%(OR 1.87),脑血管意外患病率1.8% vs 1.2%(OR 1.55)。
临床怎么用
- 作者认为该工作强化了对银屑病患者采取多学科方法并密切监测心血管危险因素以预防心血管事件的必要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Psoriasis is a very prevalent systemic chronic inflammatory disease. Major cardiovascular events are the main cause of mortality in these patients which suggests an association between psoriasis and traditional cardiovascular risk factors. OBJECTIVE: To identify classic cardiovascular risk factors and metabolic syndrome (MS) in patients with psoriasis, their possible association with its severity and compare it with the non-psoriatic population. METHODS: This is an observational and cross-sectional population study in Lleida (Spain) from a joint hospital/primary care database. RESULTS: The database comprised 398 701 individuals. There were 6868 cases registered as psoriasis (1.7%), and 499 of them (7.3%) were classified as moderate-severe psoriasis. Patients with psoriasis had a higher prevalence of traditional cardiovascular risk factors than non-psoriatic population: diabetes mellitus 2 (13.9% vs 7.4%, OR 2.01), dyslipidaemia (28.8% vs 17.4%, OR 1.92), arterial hypertension (31.2% vs 19.0%, OR 1.93), obesity (33.7% vs 28.1%, OR 1.30), altered fasting basal glycaemia (21.4% vs 15.1%, OR 1.54), low cholesterol HDL (38.1% vs 32.3%, OR 1.29), hypertriglyceridaemia (45.7% vs 35.2%, OR 1.55) and high waist circumference (75.7% vs 72.3%, OR 1.19). MS was more prevalent in psoriatic patients (28.3% vs 15.1%, OR 2.21), and cardiovascular risk factors were similar between psoriasis severity groups. Psoriatic patients had a higher prevalence of ischaemic heart disease (3.3% vs 1.8%, OR 1.87) and vascular cerebral accidents (1.8% vs 1.2%, OR 1.55). A model for MS showed a significant nonlinear relationship with age and sex and significant differences between patients with and without psoriasis. CONCLUSION: We found statistically significant differences in relation to the prevalence of cardiovascular risk factors, MS and major cardiovascular events in psoriatic patients. However, differences were not seen between psoriasis severity groups. Our work reinforces the need for a multidisciplinary approach and close monitoring of cardiovascular risk factors in these patients to prevent a cardiovascular event.
引用
- Fernández-Armenteros JM, Gómez-Arbonés X, Buti-Soler M, et al. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study. J Eur Acad Dermatol Venereol. 2018. PMID: 29953676. doi:10.1111/jdv.15159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。